Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction

New England Journal of Medicine

Volumn 344, Issue 25, 2001, Pages 1895-1903

  Montalescot, Gilles ^a   Barragan, Paul ^b   Wittenberg, Olivier ^c   Ecollan, Patrick ^a   Elhadad, Simon ^d   Villain, Philippe ^e   Boulenc, Jean Marc ^f   Morice, Marie Claude ^g   Maillard, Luc ^h   Pansiéri, Michel ⁱ   Choussat, Rémi ^a   Pinton, Philippe ^j  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Clinique Beauregard   (France)

^c Clinique des Franciscaines   (France)

^d Centre hospitalier de Lagny Marne la Vallee   (France)

^e Les Fleurs Clinic   (France)

^f Intensive Care Unit GHPCA   (France)

^g INSTITUT CARDIOVASCULAIRE PARIS SUD   (France)

^h SERVICE DE DERMATOLOGIE   (France)

ⁱ CENTRE HOSPITALIER D AVIGNON   (France)

^j Cardiovascular Therapeutic Unit   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; FIBRINOGEN RECEPTOR ANTAGONIST;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY STENT; DOUBLE BLIND PROCEDURE; FEMALE; FIBRINOLYTIC THERAPY; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RECURRENCE; STENTS; VENTRICULAR FUNCTION, LEFT;

EID: 0035927938     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200106213442503     Document Type: Article

References (36)

1. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease
2. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease
3. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)
4. Tidopidine and subcutaneous heparin as an alternative regimen following coronary stenting
5. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents
6. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting: The Full Anticoagulation versus Aspirin and Ticlopidine (FANTASTIC) study
7. Acute and nine-month clinical outcomes after "suboptimal" coronary stenting: Results from the STent Antithrombotic Regimen Study (STARS) Registry
8. GPIIb/IIIa antagonists: Pathophysiologic and therapeutic insights from studies of c7E3 Fab
9. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angiography
10. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: Results at six months
11. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: The CAPTURE Study
12. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization
13. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors
14. Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): A randomised, placebo-controlled trial
15. Fibrinogen after coronary angioplasty as a risk factor for restenosis
16. Acute platelet inhibition with abciximab does not reduce in-stent restenosis (ERASER study)
17. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction
18. Stenting in acute myocardial infarction: Observational studies and randomized trials
19. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction
20. Coronary angioplasty with or without stent implantation for acute myocardial infarction
21. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction
22. Left ventricular volume, mass and related measures: Usefulness in determination of ventricular function
23. Coronary artery dimensions from cineangiograms: Methodology and validation of a computer assisted procedure
24. Digital radiographic assessment of coronary arterial diameter and videodensitometric cross-sectional area
25. Permanent electronic storage of angiographic images in the catheterization laboratory: High-resolution and real-time acquisition on optical laserdiscs
26. Qualitative and quantitative angiography
27. Thrombolysis in Myocardial Infarction (TIMI) Trial - Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase
28. Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: Results of the EPISTENT (Evaluation of Platelet IIb/IIIa Inhibition for Stenting Trial) diabetic substudy
29. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction
30. Time from symptom onset to treatment and outcomes after thrombolytic therapy
31. Pre-hospital and hospital time delays in thrombolytic treatment in patients with suspected acute myocardial infarction: Analysis of data from the EMIP study
32. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: Results from the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes (GUSTO-IIb) trial
33. Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis
34. American College of Chest Physicians Conference on Antithrombotic Therapy
35. Effects of glycoprotein IIb/ IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction
36. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: The CLopidogrel Aspirin Stent International Cooperative Study (CLASSICS)